FolioLanternBeta
ELVElevance Health

Amy Schulman

Director at Elevance Health, as of May 15, 2026Sold $7K of stock in the past 12 months: 100% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
781
shares held after the latest filing, Elevance Health
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
26
shares sold, past 12 months
1
days with sales
$7K
largest single day, Mar 12, 2026
3
companies filed for

Share of stake sold at Elevance Health is not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMar 2026: $7K no plan disclosed$7KMarAprMayJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Elevance Health (ELV)DirectorFeb 3, 2026May 15, 2026
Pfizer (PFE)Former Former Exec. Vice PresidentJun 27, 2008Jan 2, 2014
Zoetis (ZTS)Former DirectorFeb 8, 2013Feb 8, 2013

Also a director at

Zoetis (ZTS) (no filing in the last 18 months)

Recent filings

The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.